Internal Medicine · Nashville, TN
NPI
1376538207
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2400 Patterson St, Suite 400
Nashville, TN, 37203
Phone (615) 342-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,164 services
Medicare patients, 2024
222
Average age 76
Drug cost, 2024
$749K
8,342 prescriptions
Company payments, 2025
$117
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepinder S Bal was code 99214 (office e&m - established), 363 times for 191 patients. In total Deepinder S Bal billed 1,164 services in 22 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 363 | 191 | $84.12 | $31K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 127 | 127 | $125.13 | $16K |
| 99213 Office E&M - Established | Office | 81 | 66 | $53.14 | $4,304 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 19 | $29.78 | $566 |
| 90653 Vaccine Product | Office | 17 | 17 | $81.82 | $1,391 |
By year: 2022 $43K for 1,015 services; 2023 $51K for 1,105 services; 2024 $67K for 1,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepinder S Bal prescribed most often to Medicare patients was Gabapentin, with 390 prescriptions and refills. In total Deepinder S Bal wrote 8,342 Medicare prescriptions that cost $749K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 390 | 420 | 56 | $3,458 |
| Amlodipine Besylate Generic | 385 | 1,071 | 119 | $1,725 |
| Atorvastatin Calcium Generic | 319 | 881 | 95 | $3,323 |
| Pravastatin Sodium Generic | 296 | 822 | 87 | $5,232 |
| Levothyroxine Sodium Generic | 278 | 776 | 85 | $3,003 |
| Telmisartan Generic | 254 | 661 | 75 | $8,131 |
| Rosuvastatin Calcium Generic | 221 | 570 | 66 | $2,719 |
| Losartan Potassium Generic | 208 | 531 | 56 | $2,607 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 200 | 200 | 23 | $6,364 |
| Pantoprazole Sodium Generic | 196 | 536 | 56 | $2,668 |
| Carvedilol Generic | 180 | 503 | 53 | $1,311 |
| Metformin Hcl Er Metformin Hcl | 171 | 455 | 50 | $1,954 |
| Metoprolol Succinate Generic | 152 | 401 | 43 | $2,445 |
| Duloxetine Hcl Generic | 139 | 314 | 33 | $2,521 |
| Lorazepam Generic | 134 | 134 | 18 | $701 |
Brand drugs: 949 claims; generic drugs: 7,325 claims; opioid claims: 385.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepinder S Bal $117 ($117 in general payments such as food, travel and fees) from 1 company. The largest payer was Axsome Therapeutics, Inc. with $117.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 1 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.